Botox (onabotulinumtoxinA, AbbVie/Allergan Aesthetics) and Dysport (abobotulinumtoxinA, Galderma) are both FDA-cleared neuromodulators, but they differ in molecular weight, diffusion radius, onset kinetics, and unit-to-unit potency: differences that affect clinical outcomes, patient expectations, and your supply costs.
Injectables
Botox vs Dysport: Clinical Differences, Dosing, and Economics for Injectors
How onset, diffusion, unit conversion, and cost structure differ between the two leading neuromodulators, and when to stock each.
1-YEAR MOVE
ABBV
▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |